News
University of Arizona Health Sciences immunobiologist Dr. Deepta Bhattacharya says the COVID-19 vaccine is safe, and he will take it when it becomes available.
Antibody tests, groundbreaking research and community outreach are a few of the ways the University of Arizona Health Sciences met the test of a pandemic.
UArizona Health Sciences immunobiologists have created a five-module chimeric antigen receptor T cell that is showing early potential to fight Type 1 diabetes.
At 7,541 administered from Nov. 9-13, the university’s COVID-19 testing, which continues through Nov. 25, is succeeding in goal to test large numbers of students before they head home for holidays.
The university will expand in-person instruction with half the semester left to go, bringing about 1,500 more students to campus a week.
Researchers are expanding research showing that creating good sleeping habits can help people quit smoking to focus on smokers who are HIV positive.
The contribution will allow UArizona researchers to continue developing better, more efficient and effective tests for people across the state.
The university also will conduct a testing blitz prior to the Thanksgiving holiday in an effort to reduce travel-related spread of COVID-19.